Pinned Tweet
If a toxic person is unwilling to change and continues to cause harm, ending the relationship entirely may be necessary.
Cut All Ties with Toxic People .
Life is a beautiful choice 🌻
URGENT Cairo: 52M with relapsing multiple myeloma needs Elrexfio 76 mg weekly dose TOMORROW. Completed 3-week protocol. Pfizer Oncology says unavailable. Any stock / hospital / named-patient access in Egypt? Please help RT. @pfizer @PfizerOncMed #Elrexfio #MultipleMyeloma #Cairo
51
Among patients with STEMI who were undergoing primary PCI, low-dose prasugrel monotherapy initiated before PCI was not noninferior to DAPT for 12 months.
No aspirin for primary PCI…
1
93
“lowering lipoprotein(a) levels with pelacarsen did not improve cardiovascular outcomes.”
Poor little a remains little in cardiology…
79
Statin discontinuation in older adults with multiple comorbidities but without cardiovascular disease was noninferior to continuing statins.
Finally, stop statin without guilt…
69
For patients with ischemia, an invasive strategy, in which cardiac catheterization guided revascularization decisions, did not reduce mortality compared with a conservative strategy alone.
Again and again…
44
•"When desperation drives the search for healing, a patient will accept false promises over safe medicine."
— Prof Zak
87
Patients left stuck in hospital 'for weeks' as health and social care system delays pile pressure on NHS ahead of winter
513
The PESI is pulmonary embolism severity index.
In the new 2026 guidelines, it is primarily used to identify Low Risk (Category B) patients who are safe for early hospital discharge.
<85 points: discharge
>85 points: admit
🤖 Made with AI
90
Perhaps it's better to group category A+B as low risk, C+D intermediate, and category E as high risk.
It works well for our residents and medical students.
Here's my proposal 👇
🤖 Made with AI
2
74
The 2026 PE categories are not practical and require further simplification:
Category A: immediate discharge.
Category B: early hospital discharge.
Category C: requires hospitalization.
Category D: advanced monitoring.
Category E: immediate advanced therapies.
84
Glucagon receptor–GLP-1 receptor dual agonist:
The evidence is clearly supporting the use of GLP-1 RDA,...
MAKE'EM AFFORDABLE, PLZ.
72
Q) Should target HbA1c be < 6.5% for all DM patients?
A) No.
Guidelines reject "one size fits all" targets:
🎯 Healthy/Young: <7.0% (Prevents organ damage)
⚠️ Older/Heart Disease: <8.0% (Prevents fatal hypoglycemia)
We don't let HbA1c soar; we personalize the goal for safety.
1
111















